---

---

published : This year    tags : Research   

save search

---

Cybin Announces Publication of Research Manuscript in the Journal of Medicinal Chemistry
Published: 2024-04-18 (Crawled : 14:00) - biospace.com/
CYBN | News | $0.3699 -1.47% 1.05% 1.7M |

n/a

| 0.0% | O: -2.0% H: 0.0% C: 0.0%
publication research

---

Immutep Appoints Leading Research Institute to Conduct First-in-Human Phase I Study of IMP761
Published: 2024-04-18 (Crawled : 12:00) - globenewswire.com
IMMP | News | $2.205 -2.43% -2.73% 270K |

Health Technology

| 4.15% | O: 0.46% H: 0.0% C: 0.0%
imp761 institute research study

---

Genpact Ranked as Market Leader in HFS Research Inaugural Customer Experience Service Providers Horizon Report
Published: 2024-04-18 (Crawled : 12:00) - prnewswire.com
G | News | $30.89 1.08% 0.0% 1.3M |

Commercial Services

| -0.49% | O: -0.68% H: 0.0% C: 0.0%
report service research market

---

Quebec's INESSS recommends BEYFORTUS for the prevention of RSV for all infants 8 months of age and younger(1)
Published: 2024-04-18 (Crawled : 12:00) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -0.52% | O: -1.81% H: 0.0% C: 0.0%
beyfortus for rsv

---

Calliditas Therapeutics Presents Additional Data Analyses from the Phase 3 NeflgArd trial of Nefecon in Primary IgA Nephropathy at the ISN World Congress of Nephrology 2024
Published: 2024-04-18 (Crawled : 12:00) - biospace.com/
CALT | News | $18.3 -2.35% -2.4% 6.1K |

Health Technology

| -2.9% | O: 1.53% H: 0.0% C: 0.0%
nephropathy congress world nefecon trial therapeutics

---

Aldeyra Therapeutics to Host Research & Development Day on April 25, 2024
Published: 2024-04-18 (Crawled : 12:00) - biospace.com/
ALDX | News | $3.99 0.5% 0.5% 430K |

Health Technology

| -1.02% | O: 1.28% H: 0.0% C: 0.0%
day research therapeutics development

---

Mascara Market to Reach $14.1 billion, Globally, by 2032 at 8.3% CAGR: Allied Market Research
Published: 2024-04-18 (Crawled : 09:00) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 34K |

Communications

| Email alert Add to watchlist
reach research market

---

ACM Research to Release First Quarter 2024 Preliminary Revenue Range on April 26, 2024 and Full Financial Results on May 8, 2024
Published: 2024-04-17 (Crawled : 20:00) - globenewswire.com
ACMR | $27.42 -1.76% -1.79% 1.3M |

Producer Manufacturing

| Email alert Add to watchlist
first revenue research financial results

---

Leading Institutions Enroll First Alzheimer’s Patients Receiving Amyloid-Targeting Therapy in CARE PMR Study
Published: 2024-04-17 (Crawled : 16:00) - biospace.com/
HYPR | $0.81 -10.99% -12.35% 190K |

Manufacturing

| -8.08% | O: 0.0% H: 0.0% C: -8.08%
first alzheimer’s care enroll therapy study

---

Egg Substitutes Market to Reach $5.2 Billion Globally by 2032 at 16.6% CAGR: Allied Market Research
Published: 2024-04-17 (Crawled : 14:00) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 34K |

Communications

| Email alert Add to watchlist
reach research market

---

Terran Biosciences Granted US Patent for the World’s First New Forms of MDMA, Potentially Clearing the Path to a Future 505(b)(2) Approval
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 34K |

Communications

| Email alert Add to watchlist
first patent granted approval for

---

Outset Medical and U.S. Renal Care Announce Multi-Year Agreement to Accelerate and Grow Home Dialysis Across the U.S.
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
OM | $2.24 3.7% 3.57% 850K |

Health Technology

| 3.85% | O: 3.85% H: 6.94% C: 0.0%
multi-year renal care dialysis medical home agreement

---

NRx Pharmaceuticals, Inc. Announces New Data on NRX-101
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
NRXP 1 d | $3.025 -27.63% -38.18% 760K |

Manufacturing

| -2.79% | O: -0.93% H: 0.94% C: -1.88%
nrx-101

---

Ventus Therapeutics Announces Results from Phase 1 Clinical Trial of VENT-02, a Novel, Orally Administered, Brain-Penetrant NLRP3 Inhibitor
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
NVO | $122.75 -1.43% 0.0% 2.8M |

Health Technology

| 0.87% | O: 1.22% H: 0.21% C: -0.34%
vent-02 trial therapeutics results

---

NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses
Published: 2024-04-17 (Crawled : 12:00) - biospace.com/
NBY | $0.084 1.33% 0.0% 3.5M |

Health Technology

| 10.96% | O: 38.7% H: 0.0% C: -20.0%
sales first revenue care pharmaceuticals for

---

Zinc-Air Battery Market to Reach $521.1 Million Globally by 2032 at 4.2% CAGR: Allied Market Research
Published: 2024-04-17 (Crawled : 07:00) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 34K |

Communications

| Email alert Add to watchlist
million reach battery research market

---

Temperature Controlled System Market to Reach $2.5 Billion Globally by 2032 at 3.9% CAGR: Allied Market Research
Published: 2024-04-17 (Crawled : 06:00) - prnewswire.com
JCI | News | $63.77 0.13% 0.0% 3.2M |

Producer Manufacturing

| -0.8% | O: 0.9% H: 0.0% C: -1.68%
HON | News M | $191.15 0.42% 0.41% 2M |

Producer Manufacturing

| -1.36% | O: -0.73% H: 0.0% C: 0.0%
CARR | $53.38 -1.6% 0.0% 3.1M |

Producer Manufacturing

| 0.02% | O: 0.02% H: 0.0% C: 0.0%
reach research system market

---

Petros Pharmaceuticals Receives Positive Response from FDA Following Recent Demonstration of Technology Component in Pursuit of OTC Status for STENDRA(R) (avanafil)
Published: 2024-04-16 (Crawled : 16:00) - biospace.com/
PTPI | $0.69 0.0% 230K |

| -11.89% | O: 9.85% H: 4.63% C: -18.04%
fda positive pharmaceuticals for technology response

---

LED Billboard Market to Reach $9,795.2 million, Globally, by 2032 at 10.8% CAGR: Allied Market Research
Published: 2024-04-16 (Crawled : 14:00) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 34K |

Communications

| Email alert Add to watchlist
reach research market

---

Emphysema Treatment Market to Reach $8.7 Billion, Globally, by 2032 at 3.3% CAGR: Allied Market Research
Published: 2024-04-16 (Crawled : 14:00) - prnewswire.com
VTRS | $11.11 0.09% 0.09% 3.5M |

Health Technology

| -1.94% | O: -0.53% H: 0.0% C: -1.24%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| -1.19% | O: -1.46% H: 0.0% C: 0.0%
PHG | $19.98 -0.84% 0.0% 500K |

Health Technology

| -2.52% | O: -1.21% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| -2.22% | O: -1.19% H: 0.52% C: -0.17%
VRNA | $16.1 -1.83% -1.86% 490K |

Health Technology

| 3.8% | O: 1.65% H: 2.43% C: 0.87%
reach treatment research market

---

Gainers vs Losers

64%

36%

Top 10 Gainers

AGBA | News | $1.02 155.0% 57.94% 120M |

Finance

ZCMD | $2.86 108.76% 52.1% 2.3M |

Commercial Services

INVO | $1.555 104.6% 51.13% 5M |

Health Technology

ISPC | $0.437 105.16% 49.53% 37M |

Professional, Scientific, and T...

WLGS | News | $0.92 84.0% 45.65% 1.6M |

OST | $0.499 21.38% 45.26% 1.9M |

XPON | News | $3.1 60.62% 37.74% 17M |

TIRX | $0.7 44.39% 30.74% 58M |

BNTC | News | $6.92 44.17% 30.64% 3.5M |

Health Technology

GGE | $0.035 19.86% 29.3% 64M |

---

Your saved searches

---